Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk

21 juni 2018 uppdaterad av: Grace Ng Beng Hua, SingHealth Polyclinics

A Randomized Controlled Trial to Evaluate the Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk

The chronic disease burden is increasing worldwide leading to a rise in the demand for primary healthcare and a shortage of primary care physicians. Addressing this shortage entails a multi-prong approach with innovations in care delivery, greater use of healthcare technology, and more efficient use of all healthcare providers on the care team.

We previously developed an interactive self-service healthcare kiosk (Self-empowering and enabling kiosk - SEEK® MyHealthKiosk) for the management of patients with stable chronic disease in the primary care setting. A feasibility study using SEEK showed high levels of acceptance and satisfaction from patients and healthcare providers.

The aim of this follow-up study is to evaluate the health outcomes of patients with stable chronic disease who are on kiosk management compared to patients who are on routine management by nurse clinicians. We hypothesize that patients who are managed by the kiosk continue to maintain good disease control that are comparable to patients who are managed by a nurse clinician.

Studieöversikt

Status

Okänd

Intervention / Behandling

Detaljerad beskrivning

Patients who seek primary healthcare vary in their time and resource requirements. Patients with acute medical conditions or poorly controlled chronic disease typically require more time and attention compared to patients with stable chronic disease.

Patients with chronic disease routinely make follow-up visits to their primary care provider for assessment of their chronic disease status and for changes to their medications as necessary. Patients with well-controlled stable chronic disease may go through several visits to their primary care provider in 3 or 4-monthly intervals with little or no change to their medication regimen. These patients have to wait in line with the rest of the patient crowd for a doctor's consultation before getting their regular supply of medications. We hence saw the potential of replacing some of these physician visits with an automated healthcare kiosk so that if the disease condition of such patients remained stable, they can continue on their current medications without having to see a doctor.

We previously described the feasibility of using an automated healthcare kiosk (SEEK® MyHealthKiosk) for the management of patients with stable chronic disease in the primary care setting. We propose a follow-up study to show equivalence of health outcomes for patients managed with SEEK compared to the current standard of care. The study will be a 2-armed randomized controlled trial of 120 patients with stable chronic disease on 4-monthly follow-up visits over a 12-month period. Patients will be assigned randomly to intervention or control groups to receive kiosk or nurse management respectively. The main primary outcome measure is the overall chronic disease control of the patients. Other primary outcome measures are the blood pressure and low-density lipoprotein cholesterol levels for patients without diabetes; and blood pressure, low-density lipoprotein cholesterol and hemoglobin A1c levels for patients with diabetes. Secondary outcome measures are visit duration, patient satisfaction with the management process, health-related quality of life, and the occurrence of any adverse event.

The potential benefits from the use of SEEK are:

  1. Appropriate stratification of patient care needs so that more time and resources can be channeled to patients with complex or acute needs;
  2. Patient empowerment in the management of their chronic health conditions, with flexibility of self-care and monitoring and decreased dependency on healthcare providers;
  3. Substitution of nurse clinicians for the management of stable chronic disease;
  4. Reduction in the number of doctor visits per year for patients with stable chronic disease.

Studietyp

Interventionell

Inskrivning (Förväntat)

120

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Singapore, Singapore
        • Rekrytering
        • SingHealth Polyclinics - Punggol
        • Kontakt:
          • Executive
          • Telefonnummer: 6643 6969

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

21 år till 75 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • are between the ages of 21 and 75 years
  • have at least one chronic medical condition that includes hypertension, hyperlipidemia, diabetes mellitus
  • have blood pressure, low-density lipoprotein cholesterol (LDL-C) and HbA1c levels within the recommended targets according to the Ministry of Health Singapore clinical practice guidelines for their current and last follow-up visits
  • are able to provide informed consent.

Exclusion Criteria:

  • have serum creatinine more than 140 mmol/L (from tests done within the past year)
  • have serum potassium less than 3.5 mmol/L or more than 5 mmol/L (from tests done within the past year)
  • have overt proteinuria (urine protein:creatinine ratio more than 0.5)
  • were discharged from hospital or specialist follow-up within the last 6 months
  • have any pending laboratory or investigation result
  • are scheduled for any laboratory investigation within the next 4 months (except HbA1c or panel test)
  • have any new complaint related to their chronic medical conditions
  • have a known history of white coat hypertension

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Övrig
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Kiosk intervention group

SEEK automates the management of patients with stable well-controlled chronic disease. SEEK has the following capabilities:

  • Collects patient information using patient-specific identification
  • Prompts the user for answers to screening questions for acute conditions
  • Measures relevant physiological parameters: blood pressure, height, weight; and calculates body mass index
  • Triages patients based on responses to screening questions, physiological parameters and blood test results
  • Provides recommendations to the patient on the care plan, self management and lifestyle choices
Andra namn:
  • SEEK® MyHealthKiosk
Inget ingripande: Nurse clinician control group

Vad mäter studien?

Primära resultatmått

Resultatmått
Tidsram
Blodtryck
Tidsram: 12 månader
12 månader
Hemoglobin A1c
Tidsram: 12 månader
12 månader
Disease control
Tidsram: 12 months
12 months
Low-density lipoprotein cholesterol
Tidsram: 12 months
12 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Biverkningar
Tidsram: 12 månader
12 månader
Visit duration
Tidsram: 8 months
8 months
Patient satisfaction questionnaire
Tidsram: 12 months
The following areas of patient satisfaction will be scored on a Likert scale: convenience of visit schedule, location of kiosk or nurse consultation, appropriateness of management, duration of time spent in kiosk usage or nurse consultation, and the replacement of a doctor's visit by the kiosk or nurse clinician. Qualitative feedback will be captured via free-text inputs.
12 months
Health-related quality of life questionnaire
Tidsram: 12 months
Health-related quality of life will be assessed using the EQ-5D-5L questionnaire.
12 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

21 juni 2018

Primärt slutförande (Förväntat)

1 september 2019

Avslutad studie (Förväntat)

1 september 2019

Studieregistreringsdatum

Först inskickad

4 september 2017

Först inskickad som uppfyllde QC-kriterierna

4 september 2017

Första postat (Faktisk)

6 september 2017

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

26 juni 2018

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

21 juni 2018

Senast verifierad

1 juni 2018

Mer information

Termer relaterade till denna studie

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Hypertoni

Kliniska prövningar på Kiosk intervention group

3
Prenumerera